User menu

Phase 2 randomised trial of oral C5A receptor antagonist CCX168 in ANCA-associated renal vasculitis

Bibliographic reference Jayne, D. R. W. ; Bruchfeld, A. ; Schaier, M. ; Ciechanowski, K. ; Harper, L. ; et. al. Phase 2 randomised trial of oral C5A receptor antagonist CCX168 in ANCA-associated renal vasculitis.51ST ERA-EDTA CONGRESS (Amsterdam, du 31/05/2014 au 03/06/2014). In: Nephrology, Dialysis, Transplantation, Vol. 29, no.suppl 3, p. iii27 (2014)
Permanent URL http://hdl.handle.net/2078.1/150608